Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats

British Journal of Pharmacology

Volumn 128, Issue 6, 1999, Pages 1275-1283

  Fujita, Tomoe ^a   Hayashi, Izumi ^a   Kumagai, Yuji ^a   Inamura, Naoya ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ATP sensitive potassium channel blocker; Glibenclamide; Osmotic diuretic; Potassium; Renal kallikrein secretion; Volume load

Indexed keywords

DIURETIC AGENT; GLIBENCLAMIDE; KALLIKREIN; N (1 ADAMANTYL) N' CYCLOHEXYL 4 MORPHOLINECARBOXAMIDINE; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; KIDNEY CORTEX; KIDNEY SLICE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINE VOLUME;

EID: 0032712293     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702899     Document Type: Article

References (46)

1. BARDEN, A.E., BEILIN, L.J. & VANDOGEN, R. (1988). Effect of potassium supplementation on blood pressure and vasodilator mechanisms in spontaneously hypertensive rats. Clin. Sci., 75, 527-534.
2. BARDEN, A.E., BEILIN, L.J., VANDOGEN, R. & ROUSE, I.L. (1985). Influence of age, sex and potassium excretion on urinary prostaglandins in children. Clin. Sci., 68, 601-604,
3. BARDEN, A.E., VANDOGEN, R. & BEILIN, L.J. (1987). Increases in urinary kallikrein activity and prostanoid synthesis after dietary potassium supplementation. Clin. Exp. Pharmacol. P., 14, 565-572.
4. BATTARBEE, H.D., FUND, D.P. & DAILEY, J.W. (1979). The effect of dietary sodium and potassium upon blood pressure and catecholamine excretion in the rat. Proc. Soc. Exp. Biol. Med., 161, 32-37.
5. + channel II. Cloning and distribution of alternative forms. Am. J. Physiol., 268, F1132-F1140.
6. BRANDIS, M., KEYES, J. & WINDHAGER, E.E. (1972). Potassium-induced inhibition of proximal tubular fluid reabsorption in rats. Am. J. Physiol., 222, 421-427.
7. EMANUEL, D.A., SCOTT, J.B. & HADDY, F.J. (1959). Effect of potassium on small and large blood vessels of the dog forelimb. Am. J. Physiol., 197, 637-642.
8. FEJES-TOTH, G. & FEJES-TOTH, A.N. (1984). Effect of aldosterone on urinary kallikrein and prostaglandin excretion in the rat. J. Physiol., 354, 79-88.
9. FIGUEROA, C.D., CAORSI, I., SUBIABRE, J. & VIO, C.P. (1984). Immunoreactive kallikrein localization in the rat kidney. J. Histochem. Cytochem., 32, 117-121.
10. FUJITA, T. & ANDO, K. (1984). Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives. Hypertension. 6, 184-192.
11. + loading and a blockade of ATP-sensitive potassium channels augment renal kallikrein secretion. Immunopharmacol., In press.
12. FUJITA, T. & SATO, Y. (1983). Natriuretic and antihypertensive effects of potassium in DOCA-salt hypertensive rats. Kid. Int., 24, 731-739.
13. GIEBISCH, G. (1995). Renal potassium channels: an overview. Kidney Int., 48, 1004-1009.
14. GREGER, R. (1985). Ion transport mechanisms in thick ascending limb of Henle's loop of mammalian nephron. Phys. Rev., 65, 760-797.
15. GUILLEMARE, E., HONORE, E., WEILLE, J.D., FOSSET, M., LAZDUNSKI, M. & MEISHERI, K. (1994). Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells. Mol. Pharmacol., 46, 139-145.
16. GUDER, W.G., HALLBACH, J., FINK, E., KAISSLING, B. & WIRTHENSOHN, G. (1987). Kallikrein (kininogenase) in the mouse nephron: effect of dietary potassium. Biol. Chem. Hoppe-Seyler, 368, 637-645.
17. HAGIWARA, Y., KOJIMA, M., HAYASHI, I. & OH-ISHI, S. (1994). Demonstration of derivation of rat urinary bradykinin from plasma low molecular-weight kininogen: a study using kininogen-deficient rats. Biochem. Biophys. Res. Commun., 204, 1219-1224.
18. HAYASHI, I., FUJITA, T., MAJIMA, M. & KATORI, M. (1999). A secretory mechanism of renal kallikrein by a high potassium ion; a possible involvement of ATP-sensitive potassium channel. Immunopharmacol., In press.
19. HENQUIN, J.C. & LAMBERT, A.E. (1974). Cationic environment and dynamics of insulin secretion. II. Effect of a high concentration of potassium. Diabetes, 23, 933-942.
20. 86Rb fluxes and membrane potential in pancreatic B cells. Biochem. Pharmacol., 31, 1407-1415.
21. HIMATHONGKAM, T., DLUHY, R.G. & WILLIAMS, G.H. (1975). Potassium-aldosterone-renin interrelationships. J. Clin. Endocrinol. Metab., 41, 153-159.
22. HORWITZ, D., MARGOLIUS, H.S. & KEISER, H.R. (1978). Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man. J. Clin. Endocrinol. Metab., 47, 296-299.
23. ITO, H., MAJIMA, M., NAKAJIMA, S., HAYASHI, I., KATORI, M. & IZUMI, T. (1999). Effect of prolonged administration of a urinary kininase inhibitor, ebelactone B on the development of deoxycorticosterone acetate-salt hypertension in rats. Brit. J. Pharmacol., 126, 613-620.
24. KUBOTA, T., BIAGI, B.A. & GIEBISCH, G. (1983). Intracellular potassium activity measurements in single proximal tubules of Necturus kidney. J. Membrane Biol., 73, 51-60.
25. LAUAR, N., SHACKLADY, M. & BHOOLA, K.D. (1982). Factors influencing the in vitro release of renal kallikrein. In: Fritz, H., Dietze, G., Fielder, F.H. & Haberland, G.L. (eds). Recent progress in kinins. Basel Birkhauser: Basel, pp 542-552.
26. LUDENS, J.H., CLARK, M.A., SMITH, M.P. & HUMPHREY, S.J. (1995). Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats. J. Cardiovasc. Pharmacol., 25, 404-409.
27. MAJIMA, M., IKEDA, Y., KURIBAYASHI, Y., MIZOGAMI, S., KATORI, M. & AOYAGI, T. (1995). Ebelactone B, an inhibitor of urinary carboxypeptidase Y-like kininase, prevents the development of deoxycorticosterone acetate-salt hypertension in rats. Eur. J. Pharmacol., 284, 1-11.
28. MAJIMA, M. & KATORI, M. (1995). Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system. Trends Pharmacol. Sci., 16, 239-246.
29. MAJIMA, M., KATORI, M., HANAZUKA, M., MIZOGAMI, S., NAKANO, T., NAKAO, Y., MIKAMI, R., URYU, H., OKAMURA, R., MOHSIN, S.S.J. & OH-ISHI, S. (1991). Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension, 17, 806-813.
30. MAJIMA, M., YOSHIDA, O., MIHARA, H., MUTO, T., MIZOGAMI, S., KURIBAYASHI, Y., KATORI, M. & OH-ISHI, S. (1993). High sensitivity to salt in kininogen-deficient Brown Norway Katholiek rats. Hypertension, 22, 705-714.
31. MARGOLIUS, H.S., HOROWITZ, D., PISANO, J.J. & KEISER, H.R. (1974). Urinary kallikrein excretion in hypertensive man: relationships to sodium intake and sodium-retaining steroids. Circ. Res., 35, 820-825.
32. MERSEY, J.H., WILLIAMS, G.H., EMANUEL, R., DLUHY, R.G., WONG, P.Y. & MOORE, T.J. (1979). Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension. J. Clin. Endocrinol. Metab., 48, 642-647.
33. MOHSIN, S.S.J., MAJIMA, M., KATORI, M. & SHARMA, J.N. (1992). Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensive rats. Asia. Pacific. J. Pharmacol., 7, 73-82.
34. MURAKAMI, E., HIWADA, K., KOKUBU, T. & IMAMURA, Y. (1989). Effect of oral potassium on urinary kallikrein excretion in essential hypertension. Adv. Exp. Med. Biol., 247B, 133-137.
35. NASJLETTI, A., ERMAN, A., CAGEN, L.M., BROOKS, D.P., CROFTON, J.T., SHARE, L. & BAER, P.G. (1985). High potassium intake selectively increases urinary PGF2α excretion in the rat. Am. J. Physiol., 248, F382-F388.
36. NISHIMURA, K., ALHENC-GELAS, F., WHITE, A. & ERDOS, E.G. (1980). Activation of membrane-bound kallikrein and renin in the kidney. Proc. Natl. Acad. Sci. U.S.A., 77, 4975-4978.
37. OBIKA, L.F.O. (1989). Urinary kallikrein excretion during potassium chloride infusion in potassium-adapted rats: effect of amiloride. Clin. Sci., 77, 21-27.
38. SHIMAMOTO, K., CHAO, J. & MARGOLIUS, H.S. (1982). A method for determination of human urinary inactive kallikrein (pre-kallikrein). Tohoku J. Exp. Med., 137, 269-274.
39. STANTON, B.A. (1989). Characterization of apical and basolateral membrane conductances of rat inner medullary collecting duct. Am. J. Physiol., 256, F862-F868.
40. SUZUKI, H., KONDO, K. & SARUTA, T. (1981). Effect of potassium chloride on blood pressure in two kidney, one clip Goldblatt hypertensive rats. Hypertension, 3, 566-573.
41. SUZUKI, T., KATORI, M. & MAJIMA, M. (1997). Natriuresis induced by high potassium infusion is mediated by the renal kallikrein-kinin system in anesthetized rats. Jap. J. Pharmacol., 73 (Suppl. I), 252P.
42. SVETKEY, L.P., YARGER, W.E., FEUSNER, J.R., DELONG, E. & KLOTMAN, P.E. (1987). Double blind, placebo controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension, 9, 444-450.
43. VALDES, G., VIO, C.P., MONTERO, J. & ADVENDANO, R. (1991). Potassium supplementation lowers blood pressure and increases urinary kallikrein in essential hypertensives. J. Hum. Hypertens., 5, 91-96.
44. VANDER, A.J. (1970). Direct effects of potassium on renin secretion and renal function. Am. J. Physiol., 219, 455-459.
45. VIO, C.P. & FIGUEROA, C.D. (1987). Evidence for a stimulatory effect of high potassium diet on renal kallikrein. Kidney Int., 31, 1327-1334.
46. WANG, T., WANG, W.H., ROBBENHAAR, G.K. & GIEBISH, G. (1995). Effects of a novel KATP channel blocker on renal tubule function and K channel activity. J. Pharmacol. Exp. Ther., 273, 1382-1389.